NCT01403025
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,680 public trials
156 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01301456
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Profil Institute for Clinical Research, Inc. Chula Vista, California, United States
- Elite Research Institute Miami, Florida, United States
- Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States
- Atlanta Center for Medical Research Atlanta, Georgia, United States
NCT01585506
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Warsaw, Poland
NCT01572740
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
- Novo Nordisk Investigational Site Ebina-shi, Kanagawa, Japan
- Novo Nordisk Investigational Site Ebina-shi, Japan
- Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan
NCT02627287
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Mainz, Germany
- Novo Nordisk Investigational Site Neuss, Germany
NCT03071432
- Conditions
- Anesthesia, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Academic Medical Center Amsterdam, North Holland, Netherlands
NCT02050399
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Universidade Federal de São Carlos São Carlos, São Paulo, Brazil
NCT03151837
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Chung Shan Medical University Hospital Taichung, Taiwan
NCT03404037
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
- Locations
-
- Zagazig University, Faculty of Medicine Zagazig, Egypt
Completed
Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes
NCT02537470
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Advanced Arizona Clinical Research Tucson, Arizona, United States
- Long Beach Clinical Trials Long Beach, California, United States
- Long Beach Center for Clinical Research Long Beach, California, United States
- National Research Institute Los Angeles, California, United States